CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Thomas Schinecker

Chief Executive Officer, Roche Group, Roche Holding AG

Search every verified Thomas Schinecker interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Thomas Schinecker, Chief Executive Officer of Roche Group, commented on European investment strategy and pharmaceutical pricing in an appearance around October 2026. He stated that Europe, including Germany, faces a different situation compared to the U.S. and Asia due to a lack of growth, leading to a defensive approach he characterized as "playing not to lose." He argued that such a strategy is insufficient and that investment in growth sectors, such as pharma and biotech, is necessary, noting Germany has identified these areas for focus. Schinecker also discussed the most favored nation pricing mechanism for drugs with the U.S., explaining that the U.S. has expressed willingness to apply a correction factor based on GDP per capita, where countries with a GDP per capita 50% lower than the U.S. could pay twice the price. He indicated that Roche would launch its product first in the U.S. and hold discussions with European reimbursement agencies in the following year.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →